Evidence map›Paper›PMID 37006840›Full record

ArticleClinical case reports2023

Guillain-Barre syndrome secondary to COVID-19 infection: A case report.

Dena H Tran, Dalwinder Basra, Zaid Bilgrami, Suryanarayana R Challa, Christina Kwon, Ellen Marciniak, Avelino C Verceles

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. The firstClinical case reports · 2023
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dena H TranDivision of Pulmonary and Critical Care Medicine University of Maryland School of Medicine Baltimore Maryland USA.ORCID https://orcid.org/0000-0001-5364-6620
Dalwinder BasraDepartment of Medicine American University of Antigua College of Medicine Saint Johns Antigua and Barbuda.
Zaid BilgramiDepartment of Medicine University of Maryland Medical Center Midtown Campus Baltimore Maryland USA.
Suryanarayana R ChallaDepartment of Medicine University of Maryland Medical Center Midtown Campus Baltimore Maryland USA.ORCID https://orcid.org/0000-0003-0068-5954
Christina KwonDepartment of Medicine University of Maryland Medical Center Midtown Campus Baltimore Maryland USA.
Ellen MarciniakDivision of Pulmonary and Critical Care Medicine University of Maryland School of Medicine Baltimore Maryland USA.
Avelino C VercelesDivision of Pulmonary and Critical Care Medicine University of Maryland School of Medicine Baltimore Maryland USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guillain-Barre syndrome (GBS) is a rare autoimmune disease that often manifests as a post-viral complication. However, its association with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. We present a rare case of GBS secondary to COVID-19 infection complicated by rapidly progressive sensorimotor deterioration resistant to plasma exchange therapy.

Indexed as

autoimmune diseasecase reportcerebrospinal fluidCOVID‐19demyelinationGuillain‐Barre syndromeSARS‐CoV‐2

Identifiers

PMID37006840
PMCPMC10062311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.